Background and Purpose-Computed tomography angiography is an accurate noninvasive method to diagnose intracranial steno-occlusive disease (ICAD) at initial presentation for stroke. We aimed to identify features of computed tomography angiography associated with unfavorable outcome. Methods-We identified patients with ICAD in the Screening Technology and Outcomes Project in Stroke Study, a prospective imaging-based study of stroke outcomes, in consecutive patients with ischemic stroke or transient ischemic attack (TIA) presenting to 2 academic medical centers. All patients underwent computed tomography angiography, which were graded by 2 neuroradiologists independently. Univariate and multiple logistic regression was used to evaluate predictors of favorable outcome at 6 months, defined as a modified Rankin Scale ≤2. 
I
ntracranial steno-occlusive disease (ICAD) is the most common vascular lesion in patients with acute ischemic stroke worldwide. 1 ICAD accounts for 33% to 67% of stroke in Asian, Hispanic, and black patients, but a lower prevalence of 5% to 10% has been observed in whites. [2] [3] [4] [5] [6] [7] Recent computed tomography (CT) angiography (CTA)-based study, however, identified a higher prevalence of ICAD (21%) in whites, 8 suggesting that ICAD might be truly a global disease. ICAD portends worse prognosis with recurrent stroke risk up to 22% to 38% in 2 years, which have prompted randomized trials investigating the benefits of revascularization and aggressive medical treatment, including anticoagulation and combination antiplatelet therapies. [9] [10] [11] [12] [13] [14] [15] ICAD may be underrecognized because of incomplete vascular imaging and lack of reliable noninvasive imaging modalities. 16 Transcranial Doppler ultrasound (TCD), the most widely used modality to diagnose ICAD, is often limited by lack of temporal windows in female patients and with advanced age. 17 In the Stroke Outcomes and Neuroimaging of Intracranial Atherosclerosis trial, TCD was found to have a high negative predictive value (86%), but a low positive predictive value (36%), for the detection of intracranial stenosis compared with gold-standard digital subtraction angiography. 18 Meanwhile, CTA has been established as an accurate and reliable assessment tool for ICAD, including anterior and posterior circulations. For stenosis ≥50% confirmed by digital subtraction angiography, CTA achieved 97.1% sensitivity and 99.5% specificity, and for complete occlusion, 100% sensitivity and 100% specificity. 19 In many institutions, emergent multimodal CT assessment has facilitated the triage of patients with acute ischemic stroke for thrombolytic therapies.
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We examined the outcomes of ICAD among patients presenting with stroke or transient ischemic attack (TIA) to identify imaging features at presentation that are associated with favorable outcome.
Methods
The Screening Technology and Outcomes Project in Stroke (STOPStroke) study was a prospective cohort study conducted at 2 university-based hospitals in United States. Both institutions routinely used CT/CTA to image all suspected stroke or TIA during study period unless contraindications to intravenous contrast were present. For the present study, we identified consecutive patients with suspected acute ischemic stroke who presented to the emergency department within 24 hours of symptom onset and underwent CT and CTA. Patients with atrial fibrillation identified from medical history, at presentation and during acute phase hospitalization by ECG or telemetry, were excluded.
Nonenhanced CT and CTA acquisitions were performed according to standard departmental protocols with 8-or 16-section multidetector CT scanners (LightSpeed; GE Healthcare, Milwaukee, WI). Nonenhanced CT was performed with the patient in a head holder in the transverse plane. Representative sample parameters, with minimal variations between scanners and sites shown as ranges, were as follows: 120 to 140 kVp, 170 mA, 2-second scan time, and 5-mm section thickness. Imaging with these parameters was immediately followed by biphasic helical scanning performed at the same head tilt on nonenhanced CT. CTA was performed after a 25-second delay and administration of 100 to 140 mL of a nonionic contrast agent (Isovue; Bracco Diagnostics, Princeton, NJ) at an injection rate of 3 mL/s by using a power injector (Medrad Power Injector; Medrad, Indianola, PA) through an 18-gauge intravenous catheter. Parameters were 140 kVp, 220 to 250 mA, 0.8-to 1.0-second rotation time, 2.5-mm section thickness, 1.25-mm reconstruction interval, 3.75 mm per rotation table speed, and 0.75:1 pitch. Images were obtained from the C6 vertebral body level through the circle of Willis. Immediately afterward, a second set of images was obtained from the aortic arch to the skull base. Afterward, source images were reconstructed into standardized maximum intensity projection views of the intracranial and extracranial vasculature. Two neuroradiologists who were blinded to the clinical outcomes independently reviewed CTA source images and reconstructions to characterize stenoses or occlusions in the intracranial and extracranial circulation. Extracranial vessels segments included the common carotid artery, internal carotid artery, and vertebral artery. Intracranial vessel segments included the cavernous internal carotid artery, the first and second divisions of middle cerebral artery, the first and second divisions of anterior cerebral artery, the intracranial vertebral artery, the basilar artery, and the first division of posterior cerebral artery. The degree of stenosis was calculated using the Warfarin-Aspirin Symptomatic Intracranial Disease criteria 15 and graded as mild (<50%), moderate-to-severe (50%-99%), or occlusion (100%). For each patient, the overall burden of steno-occlusive lesions was classified as extracranial only, intracranial only, and concurrent extraintracranial lesions. The symptomatic lesion was defined as the one that best explained the clinical signs and symptoms as judged by the study neurologist. In patients with tandem lesions, the most proximal lesion with ≥50% stenosis was classified as the symptomatic lesion.
Informed consent was obtained for 6-month follow-up and collection of clinical data from patients or surrogates. Data on clinical presentation and hospital course, demographics, and imaging data collected were presented to an independent stroke neurologist who then adjudicated the final diagnosis as stroke, TIA, or not acute ischemic stroke. The institutional review boards of both institutions approved the study.
The primary outcome was a modified Rankin Scale (mRS) score of ≤2 at 6 months (favorable outcome). Clinical predictors included age, sex, race/ethnicity, hypertension, diabetes mellitus, coronary artery disease, peripheral vascular disease, hyperlipidemia, smoking, prior TIA, and prior stroke. Prespecified imaging predictors included presence of ICAD, multiple sites of ICAD, ICAD burden (intracranial only, concurrent extraintracranial lesions, extracranial only), site of symptomatic lesion (intracranial anterior, intracranial posterior, extracranial), and degree of stenosis (<50%, 50%-99%, 100% occlusion).
Statistical Analysis
All statistical analyses were performed using SPSS software (version 18.0, SPSS Inc, Chicago, IL). Continuous variables are reported as mean±SD or median±interquartile range. Categorical variables are reported as proportions. Baseline characteristics, risk factors, imaging factors, and outcomes among patients with or without ICAD were compared using the t test for continuous variables and Fisher exact test for categorical variables. Predictors of favorable outcome (mRS ≤2) and recurrent stroke were evaluated using univariate and multivariate logistic regression models. Multivariate models included any variable found to have a P value <0.10 in univariate testing with stepwise elimination of predictors with the highest P value, while keeping those with P value <0.05. A second model forced in age, sex, and the prespecified imaging predictors above (site of symptomatic lesion [intracranial only, extracranial only, or concurrent extraintracranial disease], degree of stenosis [mild, moderateto-severe, occlusion], and presence of multiple sites of ICAD) based on prior knowledge.
Results
Among 741 patients enrolled in the STOP-Stroke study, 697 had a final diagnosis of stroke or TIA. After excluding 158 patients with atrial fibrillation, we identified 539 patients for the current analysis. Baseline demographics, risk factors, and characteristics of vascular lesions on CTA are shown in Table 1 . The mean age was 66.0±15.2 years. Two-hundred forty patients (45%) were women. A majority (n=448, 83%) of patients were whites. The most common risk factors were hypertension (n=308, 57%), smoking (n=180, 33%), hyperlipidemia (n=114, 21%), and diabetes mellitus (n=105, 20%). Stroke was the qualifying event for 459 patients (85%). Seventy-six (14%) and 26 (5%) patients received intravenous and intra-arterial thrombolytic therapies, respectively. Twenty-six (5%) patients underwent carotid endarterectomy. The 6-month mRS was available in 481 patients (89.2%), of which 311 (58%) achieved favorable outcome (mRS ≤2). Fifty-six patients (10%) died.
ICAD was identified in 212 patients (39%), of which 96 (18%) had intracranial lesions only and 116 (22%) had concurrent extraintracranial lesions. ICAD was found in 40% (180 of 448) white patients, 41% (20 of 49) Asian patients, and 40% (10 of 25) African patients. Among 327 patients without ICAD, 80 had extracranial stenosis and 247 had no large artery lesions. The symptomatic stenosis was attributed to anterior intracranial circulation in 114 patients (21%) (cavernous internal carotid artery, 22; middle cerebral artery, 91; and anterior cerebral artery, 1); posterior intracranial circulation in 62 patients (12%) (intracranial vertebral artery, 30; basilar artery, 28; posterior cerebral artery, 4); and extracranial circulation in 116 patients (22%) (common carotid artery, 5; internal carotid artery, 109; extracranial vertebral artery, 2). Multiple sites of ICAD were found in 66 patients (12%). The degree of stenosis across all 292 symptomatic lesions was mild (<50%) in 67 (23%), moderate-to-severe (50%-99%) in 140 (48%), and occlusion (100%) in 85 patients (29%).
The baseline characteristics and outcomes of patients with and without ICAD are shown in Table 2 . There was no statistically significant difference in age, sex, or ethnicity among patients with or without ICAD. The risk factor profiles showed similar proportions with hypertension, diabetes mellitus, and hyperlipidemia. A greater proportion of patients with ICAD had prior stroke (19% versus 12%; P=0.047) and presented with acute ischemic stroke (91% versus 81%; P=0.002). Patients with ICAD were more likely to receive intravenous (22% versus 9%; P<0.001) and intra-arterial (10% versus 2%; P<0.001) thrombolytic therapies.
Stroke severity and outcomes were significantly worse among patients with ICAD compared with those without. The median National Institutes of Health Stroke Scale (NIHSS) on presentation was 9 (interquartile range, [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] Associations between clinical predictors and favorable outcome are shown in Table 3 . Patients with good outcome were younger and had less severe stroke. Women were less likely to achieve a favorable outcome than men. Patients with diabetes mellitus, concurrent extraintracranial lesions, and multiple sites of ICAD, anterior intracranial lesions, and complete occlusion were less likely to achieve favorable outcome at 6 months. In the univariate analysis, patients with advanced age (odds ratio In a subanalysis excluding patients with mild stenosis (<50%), the predictors remained independent in both models.
Discussion
We found that a high burden of ICAD on initial CTA predicted poor outcome in patients with stroke and TIA and that the overall prevalence of ICAD in acute stroke is high. Less than 50% of patients with multiple sites of ICAD or concurrent extraintracranial lesions achieved mRS ≤2 at 6 months. In our cohort, patients with ICAD had more severe stroke on presentation (P<0.001). Patients with multiple sites of ICAD, complete occlusion, or concurrent extraintracranial disease are 2 times less likely to achieve good outcome. These findings are consistent with a recent large, multicenter, prospective cohort study in China, investigating the prevalence and risk of recurrent stroke in patients with ICAD using MRA for vascular investigation. 20 Our findings are concordant with the hypothesis that hypoperfusion and thrombo-embolism are the most important stroke mechanism in patients with intracranial stenosis. 21 Multiple intracranial stenoses, concurrent extraintracranial stenosis, and complete occlusion of an intracranial artery can lead to further compromise of cerebral perfusion with ensuing ischemia and infarction. We have previously shown that intracranial large vessel occlusion is an independent predictor of poor outcomes. 22 In this study, we excluded patients with atrial fibrillation; therefore in our cohort, complete occlusion is more likely to be attributed to chronic atherosclerosis, leading to in situ thrombosis or artery-to-artery embolism. Unlike complete occlusion, patients with moderate-to-severe stenosis were not significantly associated with worse outcomes, with the caveat that we categorized lesions into mild (<50%) and moderate-to-severe (50% to 99%) stenosis, but did not distinguish between moderate (50% to 69%) and severe (70% to 99%) stenosis attributable to CTA limitations at the time of study. This finding might suggest that degree of stenosis of the symptomatic lesion alone may not adequately reflect the extent of genuine cerebral hemodynamic compromise. The benefit of revascularization by endovascular angioplasty and stenting was overshadowed by aggressive medical treatment and periprocedural complications in Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) trial. 13 Collateral circulation seems to play an important role in the assessment of cerebral hemodynamics and stroke risk. 23 It would be of interest to develop and investigate a risk stratification strategy incorporating the burden of ICAD, such as presence of multiple ICAD, concurrent extracranial stenosis, and collateral status, to identify the The use of a consistently applied standard is crucial to diagnose ICAD. The Northern Manhattan Study attributed 1% to 5% of stroke to intracranial atherosclerosis in whites; but only 68% of patients had successful TCD study to investigate the intracranial vasculature. 6 Wityk et al 7 attributed ICAD as the cause of stroke in 9% of whites, but intracranial vessels were evaluated in only 57% of patients. The prevalence of symptomatic ICAD (≥50%) among white patients with acute ischemic stroke was 15% (611 of 4157) in a recent large prospective, hospital-based cohort study performed in 11 German acute stroke units. 25 Although over 90% patients had vascular imaging, this was almost always TCD (97%) and only 3.2% patients had CTA. The low prevalence of ICAD among whites reported in prior studies is possibly because of incomplete intracranial vascular assessment; for instance, studies from Asian population consistently reported higher prevalence (33%-67%) of ICAD, in which intracranial assessment (by TCD, CTA, MRA, or digital subtraction angiography) was complete in 87% to 100% patients. [2] [3] [4] [5] We identified ICAD in 40% whites in our study, substantiating that ICAD is more prevalent in whites than previously reported. The use of emergent multimodal CTA in characterizing the burden of steno-occlusive lesions should be further explored, including 4-dimensional imaging, in triaging, and prognosticating patients with acute stroke. 26 An important strength of our study is complete vascular assessment in an unselected cohort of patients with acute stroke with varying stroke severity at presentation. All patients had extracranial and intracranial CTA performed at the emergency department except those who were contraindicated to intravenous contrast. Clinically less-stable patients with high baseline NIHSS scores were also included, who otherwise might be excluded from clinical trials or are unfit for vascular investigations, such as TCD or MRI. This improved the representativeness and generalizability of our results. Nonetheless, the true prevalence and impact of ICAD might still be overestimated; our study was not population based, and recruitment at 2 academic institutions could be biased toward more severe and advanced ICAD patients. Although we identified a higher prevalence of ICAD in whites, further studies are needed to establish ICAD as a common stroke pathogenesis. The classification of symptomatic lesion as adjudicated by the study neurologist is not robust and could be a potential bias. Because our objective was to identify outcome predictors based on initial clinical information and vascular investigations, we did not adjust for treatment during hospitalization and follow-up period. A small proportion of patients received thrombolytic therapy (14% IV, 5% IA) and neurovascular intervention (5%), which could also affect outcome.
Conclusion
Multiple intracranial and concurrent extracranial steno-occlusive lesions on CTA identify patients at high risk of poor outcome. ICAD is significantly associated with unfavorable functional outcome and high mortality at 6 months.
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